30 January 2024 | 31:57 mins.
Webinar Series
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
Early stage IP strategy pays off – Our experts Dr. Anja Lunze, LL.M. & Tobias Baus explained the pros and cons of IP protection, how to build a custom IP strategy with a matching IP portfolio, and why early patent protection is essential for biotech & pharma start-ups.
Life science technologies will require a substantial amount of (external) financing to be successful. Our leading VC experts will help you navigate the funding process and avoid unnecessary pitfalls in negotiations with investors.
In this series
Life sciences & healthcare
Coffee Break Life Sciences Start-ups | Overview page
Life sciences & healthcare
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30 January 2024
Life sciences & healthcare
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
23 February 2024
Life sciences & healthcare
Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3
20 March 2024
Life sciences & healthcare
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
Would you like to receive future invitations to our webinar series?
Then sign up for our mailing list.Related Insights
Life sciences & healthcare
Click here to find out more
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
In-depth analysis
Commercial & consumer contracts
Click here to find out more
Medical devices & the EU draft regulation on AI – new challenges for my business?
27 November 2023
In-depth analysis
by multiple authors